Advanced search
Publication Cover
Autoimmunity Volume 56, 2023 - Issue 1
Submit an article Journal homepage
3,536
Views
1
CrossRef citations to date
0
Altmetric
Research Article

SARS-CoV-2 spike-specific regulatory T cells (Treg) expand and develop memory in vaccine recipients suggesting a role for immune regulation in preventing severe symptoms in COVID-19

Alessandra Francoa Department of Pediatrics, University of California San Diego, School of Medicine, La Jolla, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4840-8182View further author information
ORCID Icon,
Jaeyoon Songa Department of Pediatrics, University of California San Diego, School of Medicine, La Jolla, CA, USAView further author information
,
Christina Chambersa Department of Pediatrics, University of California San Diego, School of Medicine, La Jolla, CA, USAView further author information
,
Alessandro Setteb Center for Autoimmunity and Inflammation, Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USAView further author information
&
Alba Grifonib Center for Autoimmunity and Inflammation, Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USAView further author information
Article: 2259133 | Received 30 Jun 2023, Accepted 10 Sep 2023, Published online: 19 Sep 2023

References

  • Merad M, Blish CA, Sallusto F, et al. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1–9.
  • Felgenhauer U, Schoen A, Gad HH, et al. Inhibition of SARS-CoV-2 by type I and type III interferons. J Biol Chem. 2020;295(41):13958–13964.
  • Kim Y-M, Shin E-C. Type I and III interferon responses in SARS-CoV-2 infection. Exp Mol Med. 2021;53(5):750–760.
  • Viox EG, Hoang TN, Upadhyay AA, et al. Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques. Sci Immunol. 2023;8(85):eadg0033.
  • Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861–880.
  • Krammer F. SARS-CoV-2 vaccines development. Nature. 2020;586(7830):516–527.
  • Zhang Z, Mateus J, Coelho CH, et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell. 2022;185(14):2434–2451.e17.
  • Jarjour NN, Masopust D, Jameson SC. T cell memory: understanding COVID-19. Immunity. 2021;54(1):14–18.
  • Harb H, Benamar M, Lai PS, et al. Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections. Immunity. 2021;54(6):1186–1199.e7.
  • Xu Z, Jiang X, Dai X, et al. The dynamic role of FOXP3+ tregs and their potential therapeutic applications during SARS-CoV-2 infection. Front Immunol. 2022;13:916411–916433.
  • Hsieh LE, Grifoni A, Dave H, et al. SARS-CoV-2-specific T cell responses and immune regulation in infected pregnant women. J Reprod Immunol. 2022;149:103464–103471.
  • Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune diseases. Nat Immunol. 2018;19(7):665–673.
  • Sakaguchi S, Mikami N, Wing JB, et al. Regulatory T cells and human diseases. Annu Rev Immunol. 2020;38(1):541–566.
  • Sallusto F, Impellizzieri D, Basso C, et al. T-cell trafficking in the central nervous system. Immunol Rev. 2012;248(1):216–227.
  • Grifoni A, Sidney J, Zhang Y, et al. A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell Host Microbe. 2020;27(4):671–680 e672.
  • Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181(7):1489 e1415–1501 e1415.
  • Reiss S, Baxter AE, Cirelli KM, et al. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells. PLoS One. 2017;12(10):e0186998.
  • Mateus J, Grifoni A, Tarke A, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370(6512):89–94.
  • Weiskopf D, Schmitz KS, Raadsen MP, et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020;5(48):eabd2071.
  • Hsieh LE, Grifoni A, Shimizu C, et al. T cells in multisystem inflammatory syndrome in children have a predominant CD4+ T helper response to SARS-CoV-2 and numerous virus-specific CD4- CD8- double negative T cells. Int J Mol Sci. 2022;23(13):7219–7233.
  • Hsieh L-E, Grifoni A, Sidney J, et al. Characterization of SARS-CoV-2 and common cold coronavirus-specific T-cell responses in MIS-C and Kawasaki disease children. Eur J Immunol. 2022;52(1):123–137.
  • Zielinski CE, Mele F, Aschenbrenner D, et al. Pathogen-induced human Th17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature. 2012;484(7395):514–518.
  • Duhen T, Duhen R, Lanzavecchia A, et al. Functionally distinct subsets of human FOXP3+ treg cells that phenotypically mirror effector Th cells. Blood. 2012;119(19):4430–4440.
  • Sakaguchi S, Vignali DA, Rudensky AY, et al. The plasticity and stability of regulatory T cells. Nat Rev Immunol. 2013;13(6):461–467.
  • Perry JA, Shallberg L, Clark JT, et al. PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection. Nat Immunol. 2015;518:197–206.
  • Moro A, Gao Z, Wang L, et al. Dynamic transcriptional activity and chromatin remodeling of regulatory T cells after varied duration of interleukin-2 receptor signaling. Nat Immunol. 2022;23(5):802–813.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.